These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32934780)

  • 1. Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with
    Mendes A; Jühlen R; Martinelli V; Fahrenkrog B
    Oncotarget; 2020 Sep; 11(36):3371-3386. PubMed ID: 32934780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUP214 in Leukemia: It's More than Transport.
    Mendes A; Fahrenkrog B
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)+ RNA Export.
    Port SA; Mendes A; Valkova C; Spillner C; Fahrenkrog B; Kaether C; Kehlenbach RH
    J Biol Chem; 2016 Oct; 291(44):23068-23083. PubMed ID: 27613868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-Associated Nup214 Fusion Proteins Disturb the XPO1-Mediated Nuclear-Cytoplasmic Transport Pathway and Thereby the NF-κB Signaling Pathway.
    Saito S; Cigdem S; Okuwaki M; Nagata K
    Mol Cell Biol; 2016 Jul; 36(13):1820-35. PubMed ID: 27114368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies.
    Takeda A; Yaseen NR
    Semin Cancer Biol; 2014 Aug; 27():3-10. PubMed ID: 24657637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto
    Oka M; Mura S; Otani M; Miyamoto Y; Nogami J; Maehara K; Harada A; Tachibana T; Yoneda Y; Ohkawa Y
    Elife; 2019 Nov; 8():. PubMed ID: 31755865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
    Lavau CP; Aumann WK; Sze SK; Gupta V; Ripple K; Port SA; Kehlenbach RH; Wechsler DS
    PLoS One; 2020; 15(4):e0232036. PubMed ID: 32343715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
    Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
    Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis.
    Ageberg M; Drott K; Olofsson T; Gullberg U; Lindmark A
    Genes Chromosomes Cancer; 2008 Apr; 47(4):276-87. PubMed ID: 18181180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report.
    Hao Q; Zhang Q; Li C; Wei S; Li Q; Song Y; Mi Y
    Oncol Lett; 2017 Dec; 14(6):7021-7024. PubMed ID: 29344131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in Drosophila.
    Xylourgidis N; Roth P; Sabri N; Tsarouhas V; Samakovlis C
    J Cell Sci; 2006 Nov; 119(Pt 21):4409-19. PubMed ID: 17032737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR.
    Sandén C; Ageberg M; Petersson J; Lennartsson A; Gullberg U
    BMC Cancer; 2013 Sep; 13():440. PubMed ID: 24073922
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhou MH; Yang QM
    Oncol Lett; 2014 Sep; 8(3):959-962. PubMed ID: 25120641
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
    Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nup214 is required for CRM1-dependent nuclear protein export in vivo.
    Hutten S; Kehlenbach RH
    Mol Cell Biol; 2006 Sep; 26(18):6772-85. PubMed ID: 16943420
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Brunetti M; Andersen K; Spetalen S; Lenartova A; Osnes LTN; Vålerhaugen H; Heim S; Micci F
    Front Oncol; 2024; 14():1371980. PubMed ID: 38571499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1.
    Bogerd HP; Echarri A; Ross TM; Cullen BR
    J Virol; 1998 Nov; 72(11):8627-35. PubMed ID: 9765402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.
    Oka M; Otani M; Miyamoto Y; Oshima R; Adachi J; Tomonaga T; Asally M; Nagaoka Y; Tanaka K; Toyoda A; Ichikawa K; Morishita S; Isono K; Koseki H; Nakato R; Ohkawa Y; Yoneda Y
    Cell Rep; 2023 Aug; 42(8):112884. PubMed ID: 37516964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Characterization of CRM1-Nup214 Interactions Reveals Multiple FG-Binding Sites Involved in Nuclear Export.
    Port SA; Monecke T; Dickmanns A; Spillner C; Hofele R; Urlaub H; Ficner R; Kehlenbach RH
    Cell Rep; 2015 Oct; 13(4):690-702. PubMed ID: 26489467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.
    Chiriches C; Nicolaisen N; Wieske M; Elhaddad H; Mehmetbeyoglu E; Alvares C; Becher D; Hole P; Ottmann OG; Ruthardt M
    PLoS Genet; 2022 Oct; 18(10):e1010463. PubMed ID: 36288392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.